• Thumbnail for COVID-19 drug development
    COVID-19 drug development is the research process to develop preventative therapeutic prescription drugs that would alleviate the severity of coronavirus...
    90 KB (13,124 words) - 04:28, 26 July 2024
  • Thumbnail for COVID-19 drug repurposing research
    safe drugs with repurposing potential against COVID-19. Drug repurposing usually requires three steps before taking the drug across the development pipeline:...
    128 KB (14,816 words) - 01:34, 9 September 2024
  • Thumbnail for Nirmatrelvir/ritonavir
    United States Food and Drug Administration (FDA) granted nirmatrelvir/ritonavir emergency use authorization (EUA) to treat COVID19. It was approved in the...
    67 KB (6,032 words) - 10:06, 8 September 2024
  • therefore was haram or forbidden for purposes of Islamic law. COVID19 drug development COVID19 drug repurposing research "(OWID) vaccination maps". Our World...
    202 KB (22,914 words) - 04:18, 21 September 2024
  • Pemivibart (category COVID-19 drug development)
    authorized for the pre-exposure prophylaxis (prevention) of COVID19. The US Food and Drug Administration (FDA) issued an emergency use authorization for...
    7 KB (399 words) - 02:33, 16 September 2024
  • Thumbnail for Lianhua Qingwen
    Lianhua Qingwen (category COVID-19 drug development)
    ingredient used to make the drug methamphetamine. Despite the ban, Lianhua Qingwen has been sold illegally in Australia as a COVID-19 treatment. Liang, Xinlu...
    16 KB (1,667 words) - 09:45, 15 August 2024
  • Thumbnail for Pfizer–BioNTech COVID-19 vaccine
    The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...
    260 KB (22,082 words) - 05:55, 13 September 2024
  • Thumbnail for Chloroquine and hydroxychloroquine during the COVID-19 pandemic
    for COVID-19. Neither drug has been useful to prevent or treat SARS-CoV-2 infection. Administration of chloroquine or hydroxychloroquine to COVID-19 patients...
    59 KB (5,538 words) - 04:22, 19 September 2024
  • Thumbnail for Molnupiravir
    Molnupiravir (category COVID-19 drug development)
    potential COVID-19 drug". Science. doi:10.1126/science.abc7055. Cully M (January 2022). "A tale of two antiviral targets - and the COVID-19 drugs that bind...
    54 KB (4,223 words) - 21:58, 7 September 2024
  • Thumbnail for Nirmatrelvir
    Nirmatrelvir (category COVID-19 drug development)
    could be replaced by a rigid pyrrolidone. These drugs had been further developed prior to the COVID-19 pandemic for other diseases including SARS. The...
    25 KB (2,010 words) - 16:27, 30 August 2024